Alzheimer's Disease Trial, Recruiting NCT05820919 Sponsor: University of Alabama, Tuscaloosa Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT05820919
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 50 or older who live in a nursing home, have been diagnosed with Alzheimer's disease or a related form of dementia, and have been identified by nursing home staff as having sleep problems

Who may not be able to join:

  • Residents who are at high risk of obstructive sleep apnea (a condition where breathing stops and starts during sleep) and are not currently receiving treatment for it, as the monitoring device used in this trial does not give accurate readings in that group
  • Residents who have a constant tremor (shaking) in both arms while at rest, or paralysis in both arms — such as some people with Parkinson's disease or similar conditions — as this also affects the accuracy of the monitoring device used

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lynn Snow, PhD, The University of Alabama

Phone: 205-201-0312

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Alabama, Tuscaloosa
Registry
ClinicalTrials.gov
Start date
7 September 2023
Est. completion
1 April 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Sleep (actigraph measurement)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov